PROTAGONIST THERAPEUTICS, INC. Key Metrics

2 years of history · ending 2025-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

EPS (Diluted)
$-2
Book Value Per Share
$10
Free Cash Flow Per Share
$1
Cash Per Share
$2
Revenue Per Share
$1
OCF Per Share
$1
Return on Equity
-20.2%
Return on Assets
-18.4%
Return on Invested Capital
-19.4%
Debt to Equity
Current Ratio
12.71
Quick Ratio
12.71
Asset Turnover
0.07
R&D / Revenue
346.2%
SBC / Revenue
99.9%
Capex / Revenue
3.5%
Working Capital
$532M
Net Current Asset Value
$524M
Invested Capital
$615M
OCF / Net Income
-0.44
FCF / Net Income
-0.43
Accruals Ratio (Sloan)
-28.1%
Net Debt
$-567M
Net Debt / EBITDA
3.62
Interest Coverage
Cash Coverage
Capex Coverage
36.27
Tangible Common Equity
$615M
TCE / Total Assets
92.0%
NOPAT
$-125M
Cash ROIC
8.7%
WC / Revenue
1156.4%
Capex / D&A
1.24
Reinvestment Rate
-0.2%
Asset Growth vs Revenue Growth
79.1%
Revenue 5Y CAGR
10.0%
Book Value 5Y CAGR
17.1%
Stock Price (FY-end)
$87
Market Cap
$5.55B
P/E Ratio
9.13
P/S Ratio
120.66
P/B Ratio
9.03
P/TB Ratio
9.03
P/OCF Ratio
96.28
P/FCF Ratio
99.01
Enterprise Value
$4.99B
EV / EBITDA
8.25
EV / Sales
108.33
EV / FCF
88.89
FCF Yield
1.0%
Shareholder Yield
-0.8%
R&D Yield
2.9%
Capex Yield
0.0%
Graham Number
$31
Shares Variation (YoY)
-2.3%
Beta (5Y)
1.07
Cost of Equity
9.8%
Cost of Debt (after tax)
52W High
$95
52W Low
$35
Trailing Return 1Y
124.2%
Trailing Return 5Y
265.4%
F-Score (Piotroski)
4.00
Z-Score (Altman)
61.55

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates